NCT04826887View on ClinicalTrials.gov

SOLTIVE™ Laser Enucleation for Treatment of Benign Prostatic Hyperplasia

CompletedOBSERVATIONAL
Enrollment

15

Participants

Timeline

Start Date

April 14, 2021

Primary Completion Date

November 30, 2022

Study Completion Date

May 2, 2024

Conditions
BPHBenign Prostatic Hyperplasia
Interventions
OTHER

SOLTIVE Thulium Laser

Use of SOLTIVE Thulium laser for HoLEP

OTHER

Standard of Care (Holmium Laser)

Use of Holmium laser for HoLEP

Trial Locations (1)

66160

University of Kansas Medcial Center, Kansas City

All Listed Sponsors
lead

University of Kansas Medical Center

OTHER